Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Omega Healthcare Investors (OHI)

Omega Healthcare Q4 AFFO rose to $0.80 per share; 2026 guidance $3.15-$3.25

Positive Impact 3 of 5 earnings Written later

Omega Healthcare reported fourth quarter and full year 2025 results in a February 4, 2026 press release filed under Form 8-K. Net income and AFFO per diluted share both rose from a year earlier, and full-year 2025 AFFO was $3.10 per diluted share versus $2.87 in 2024. The company also guided to 2026 AFFO of $3.15 to $3.25 per diluted share, which shareholders can compare with the 2025 figure.

Key points

  • Q4 2025 net income was $172 million, or $0.55 per diluted share, versus $116 million, or $0.41, in Q4 2024.
  • Q4 2025 AFFO was $250 million, or $0.80 per diluted share, versus $0.74 in Q4 2024.
  • 2026 AFFO guidance is $3.15 to $3.25 per diluted share; the board declared a $0.67 quarterly dividend on January 29, 2026, payable February 17, 2026.

The filing

CompanyOmega Healthcare Investors (OHI)
Form8-K, current report
Filed with the SECFeb 4, 2026, 4:18 PM ET
Accession number0000888491-26-000003

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.